A diagnostic test kit for detecting the PAI-1 675 Promoter 4G/5G polymorphism related to coagulation factor activity and thrombotic risk. The kit contains reagents for 32 tests and is available for QiaSymphony SP/AS systems. It is CE Mark certified.
Manufactured by
Abbiategrasso, Italy
Since 1987, Clonit has been focused in developing, manufacturing and distributing of innovative and reliable in Vitro Diagnostic Equipment and Reagents for Molecular Diagnostics. A deep expertise in Molecular Biology mixed to our strong culture of business ethics make our company a valued partner for laboratories and hospitals around the world. With our high standard and high performance IVDs portfolio, we aim to improve healthcare by enhancing and supporting the decision-making process, in line with scientific and technological evolution. Our clinical diagnostic products are used to detect a broad range of diseases in several key areas such as viral, bacterial and fungal infections (including sexually transmitted diseases, transplantation/immunocompromised related infections, tropical diseases, healthcare associated infections), thrombophilia, oncohematology and several genetic disorders . The standardization of internal quality control system and cross-checks in external reference labs allow Clonit to ensure application of the highest standards of care and quality (ISO 9001 and ISO 13485 Certified). Recently Clonit obtained the certification of products according to EU 2017/746 Regulation on In Vitro Diagnostic Medical Devices (IVDR). Certification for Class C products was issued by TÜV SÜD Product Service The company is registered and authorized by the Italian Ministry of the Health for the development, manufacturing and commercialization of Medical Diagnostic devices. We listen carefully to our customers’ needs and work closely with health care professionals to transform them into solutions that provide people a better quality of life.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Advanced Molecular Diagnostics Ltd.
United Kingdom · 5 relevant products
GENERI BIOTECH s.r.o.
Czech Republic · 7 relevant products
PlexBio Co., Ltd.
Taiwan · 4 relevant products
Nanjing Poclight Biotechnology Co.,Ltd.
China · 5 relevant products
Attomol GmbH - Molekulare Diagnostika
Germany · 9 relevant products
Beijing Richen-Force Science&Technololgy Co.,LTD.
China · 3 relevant products
TRUPCR Europe Ltd
United Kingdom · 2 relevant products
Lansion Biotechnology Co., Ltd.
China · 3 relevant products
HLB PANAGENE Co., Ltd.
South Korea · 3 relevant products
He Bei GuoGao BiotechnoLogy co .,ltd
China · 2 relevant products
41 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 97 closest product alternatives
Advanced Molecular Diagnostics Ltd. · United Kingdom
PCR-based assay for PAI-1 polymorphism detection related to fibrinolysis. Supports cardiovascular and thrombotic risk assessment.
GENERI BIOTECH s.r.o. · Czech Republic
CE IVD real-time PCR kit for detection of PI*S and PI*Z mutations in the alpha-1 antitrypsin gene using allelic discrimination with fluorescently labeled probes. Essential for screening alpha-1 antitrypsin deficiency.
PlexBio Co., Ltd. · Taiwan
A qualitative diagnostic test for the detection of 17 somatic mutations in the PIK3CA gene. This kit enables mutation-specific cancer profiling for oncology applications.
GENERI BIOTECH s.r.o. · Czech Republic
CE IVD real-time PCR kit for detection of thrombophilic mutations in human genomic DNA. Supports assessment of hypercoagulability risk and thrombotic disease predisposition.
GENERI BIOTECH s.r.o. · Czech Republic
CE IVD real-time PCR kit for apolipoprotein E genotyping in human genomic DNA. Enables detection of APOE polymorphisms relevant to cardiovascular and neurological disease risk assessment.
Nanjing Poclight Biotechnology Co.,Ltd. · China
A homogeneous chemiluminescence immunoassay for determining percentage of platelets expressing PAC-1 marker. Applied to evaluate platelet activation function in clinical diagnostics.
Attomol GmbH - Molekulare Diagnostika · Germany
A diagnostic test kit for detecting the 4G/5G polymorphism in the plasminogen activator inhibitor 1 (PAI-1) gene. The kit contains 20 test determinations and is used for genetic analysis of this fibrinolytic system variant.
Beijing Richen-Force Science&Technololgy Co.,LTD. · China
An in vitro diagnostic test kit for detecting pepsinogen I using time-resolved fluorescence immunoassay methodology. Designed for clinical laboratory use in gastric health assessment. Registration number: 苏械注准20152401384.
Nanjing Poclight Biotechnology Co.,Ltd. · China
An in vitro quantitative test kit using homogeneous chemiluminescence immunoassay intended for determination of the percentage of platelets expressing CD41 (GPIIb) as a platelet activation marker. For in vitro diagnostic use only, with 18 months shelf life and storage at 2-30°C without cold chain requirement.
TRUPCR Europe Ltd · United Kingdom
A molecular diagnostic kit for PIK3CA mutation detection. Used in solid tumour oncology for identifying phosphatidylinositol 3-kinase gene mutations in patient samples.
GENERI BIOTECH s.r.o. · Czech Republic
CE IVD real-time PCR kit for detection of CYP2C9 polymorphisms (*2A, *13, HapB3, c2846A>T) according to CPIC and DPWG guidelines. Enables personalized dosing of warfarin and other CYP2C9-metabolized medications.
Nanjing Poclight Biotechnology Co.,Ltd. · China
An in vitro quantitative test kit using homogeneous chemiluminescence immunoassay intended for determination of the percentage of platelets expressing CD61 (GPIIIa) as a platelet activation marker. For in vitro diagnostic use only, with 18 months shelf life and storage at 2-30°C without cold chain requirement.
85 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products